Preliminary Study of a Ninj1‐Loaded Bimodal Ultrasound/NIR Fluorescence Targeted Molecular Probe for Diagnosing Early‐Stage Inflammation in Coronary Microvascular Dysfunction
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202503403 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Xiaohui Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Echocardiography, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China. Hauptthemen laut MEDLINE: Inflammation, Nerve Growth Factors, Molecular Probes, Cell Adhesion Molecules, Neuronal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Scientific Research Cultivation Project of Xinjiang Medical University.
Abstract (Originalsprache)
Coronary microvascular dysfunction (CMD) exhibits a high prevalence and is associated with adverse clinical outcomes, underscoring the critical importance of early detection. Early identification of CMD can significantly improve patient prognosis. This study aims to provide a novel strategy for the precise diagnosis of CMD during its early inflammatory phase. Focusing on this key inflammatory stage in the pathological progression, we sought to identify stage‐specific molecular biomarkers. Through proteomic screening, we identified Nerve Injury‐Induced Protein 1 (Ninj1). During the inflammatory response, Ninj1 promotes leukocyte migration and macrophage transendothelial migration, thereby influencing the trafficking and distribution of inflammatory cells. IR780 is a novel near‐infrared (NIR) fluorescent agent characterized by excellent photostability and low toxicity. Loading IR780 onto nanoparticles enhances its in vivo biocompatibility and photostability while prolonging its circulation time. This project proposes a dual‐modal molecular imaging probe targeting Ninj1 and loaded with IR780, which integrates NIR fluorescence and ultrasound imaging capabilities. This probe is designed to enable the early screening of CMD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Echocardiography, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
- Xinjiang Key Laboratory of Ultrasound Medicine, Urumqi, Xinjiang, China.
ORCID-Profile: Yuming Mu
Förderung
- National Natural Science Foundation of China
- Scientific Research Cultivation Project of Xinjiang Medical University
Zitieren
APA
Xu, X., Guan, L., Tayier, B., Yuan, C., Chen, S., Shi, Q., & Mu, Y. (2026). Preliminary Study of a Ninj1‐Loaded Bimodal Ultrasound/NIR Fluorescence Targeted Molecular Probe for Diagnosing Early‐Stage Inflammation in Coronary Microvascular Dysfunction. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202503403
Vancouver
Xu X, Guan L, Tayier B, Yuan C, Chen S, Shi Q, et al. Preliminary Study of a Ninj1‐Loaded Bimodal Ultrasound/NIR Fluorescence Targeted Molecular Probe for Diagnosing Early‐Stage Inflammation in Coronary Microvascular Dysfunction. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202503403
BibTeX
@article{Xu2026,
author = {Xu, Xiaohui and Guan, Lina and Tayier, Baihetiya and Yuan, Chen and Chen, Shangke and Shi, Qi and Mu, Yuming},
title = {Preliminary Study of a Ninj1‐Loaded Bimodal Ultrasound/NIR Fluorescence Targeted Molecular Probe for Diagnosing Early‐Stage Inflammation in Coronary Microvascular Dysfunction},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202503403}
}
EUVIMED